Micazole 2%

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Micazole 2%

Property Description
Active ingredient Miconazole Nitrate
Concentration 2%
Pharmacological class Azole Antifungal, Imidazole Derivative
Primary Route Topical, Vaginal
Origin Synthetic

What Type of Medicine is Micazole 2%?

Micazole 2% is an Antifungal Agent classified specifically as a synthetic Azole Antifungal and an imidazole derivative. This medication belongs to a group of compounds that are clinically recognized for their broad-spectrum efficacy against a range of fungal pathogens. Its general therapeutic purpose is to control and eliminate the proliferation of fungi responsible for superficial mycoses, such as common fungal skin infections. Miconazole is a recognized imidazole agent effective against common yeasts and dermatophytes. This means the medication is utilized for its ability to target the typical fungi causing these types of infections.


Miconazole Nitrate: Composition and Origin

The core component of the drug is the active ingredient, Miconazole Nitrate, which provides the medication with its therapeutic properties, confirming its synthetic origin. The concentration designated as 2% specifies the strength of the product, indicating that the preparation contains two grams of Miconazole Nitrate per one hundred grams (or milliliters) of the final product base. This medication is recognized for its fundamental role in healthcare. The efficacy of this single-ingredient product against relevant fungal strains positions it as a foundational treatment.


Forms and Application Classification

Micazole 2% is exclusively designed for topical or vaginal administration, which means it is a localized treatment applied directly to the affected external area or mucous membrane. The medication is available in several common dosage forms to suit different clinical needs, including a cream, a smooth ointment, a light powder, a liquid solution, a gel, or a vaginal ovule. The variety of its available forms, such as the cream base or the powder vehicle, facilitates precise application, which is a key differentiator from formulations limited to a single form.

Regulatory References

  1. DailyMed: Miconazole Nitrate Topical

What side effects are possible with Micazole 2%?

Possible side effects and safety information

The safety profile of Micazole 2% (Miconazole Nitrate) is primarily characterized by adverse reactions localized to the application site, reflecting the medication’s minimal systemic absorption. The official regulatory documentation classifies adverse events primarily by frequency and the body system affected.


Frequency-Classified Reactions

Adverse reactions are documented based on frequency, including common and uncommon categories from clinical data and post-marketing surveillance:

Frequency Category Representative Adverse Reactions
Common Burning sensation at the application site.
Uncommon Local irritation, pruritus (itching), erythema (redness), warmth.
Not Known Hypersensitivity, angioedema (swelling), urticaria (hives), contact dermatitis.

These effects are generally classified within the General Disorders and Administration Site Conditions and Skin and Subcutaneous Tissue Disorders system-organ classes.


Serious Adverse Reactions and Constraints

The most clinically significant, though infrequent, reactions involve the Immune System, specifically severe Hypersensitivity events, which may manifest as angioedema or urticaria.

Regulatory documents specify a primary contraindication for individuals with known hypersensitivity to Miconazole or other imidazole derivatives. Additionally, a high-level safety note advises caution and monitoring for patients concurrently using oral anticoagulants, such as warfarin, due to the potential for interaction, despite low systemic absorption from topical use. For pregnancy and lactation, caution is advised due to limited data on systemic transfer, requiring the weighing of therapeutic benefit against potential risk.

Overdose and Emergency Response

Overdose and When to Seek Help: Official Regulatory Information

This section details official information concerning the potential overdose risks associated with Micazole 2% (Miconazole/Ketoconazole topical or vaginal formulations), primarily addressing the consequences of accidental oral ingestion of the product.


Documented Overdose Scenarios

Scenario Potential Manifestations (If Ingested)
Accidental Oral Ingestion Gastrointestinal distress, anorexia, fatigue, nausea, and jaundice. There is a documented potential for acute liver injury in cases of large ingestion, particularly with Ketoconazole-containing products.
Topical Overuse Excessive application may result in localized symptoms such as erythema (redness), oedema (swelling), and a burning sensation, which typically resolve upon cessation of use.

Emergency Actions and Required Monitoring

Immediate Medical Attention is Required: If Micazole 2% is swallowed (accidental ingestion), it is officially mandated to get medical help or contact a Poison Control Center right away. This applies especially to pediatric patients (children) who have ingested the product.

Management: Treatment is supportive and symptomatic as there is no specific antidote listed in the regulatory labeling. Ingestion management may include measures such as gastric lavage with activated charcoal.

Monitoring Requirement: If accidental ingestion occurs in a patient concurrently taking an oral anticoagulant (e.g., warfarin), the official profile highlights the risk of enhanced anticoagulant effect, requiring prompt monitoring of coagulation status.

Therapeutic Uses of Micazole 2%

What Micazole 2% Treats: Main Uses and Benefits

Micazole 2% is applied across therapeutic domains where additional symptomatic support is needed to manage manifestations of superficial fungal and yeast overgrowths, and is commonly used across conditions presenting with acute episodes of discomfort and inflammation.

Therapeutic Areas

The therapeutic domain includes dermatophyte infections such as Tinea corporis, Tinea pedis, and Tinea cruris, alongside vulvo-vaginal candidiasis and cutaneous candidiasis. The medication may assist with managing symptoms that create noticeable physiological strain, addressing clusters of discomfort like intense itching, burning sensation, soreness, and abnormal scaling.

Patient Benefit

By focusing on the localized fungal presence, the medication assists with maintaining functional stability when symptoms are more noticeable. It may support patients during difficult episodes by easing distress and contributes to improved comfort during periods of heightened symptoms.


Quick Fact: Relief for Irritative States This medication is commonly used to help with conditions characterized by periods of heightened symptoms, often related to inflammatory or irritative states such as acute pruritus and erythema associated with fungal colonization.

Regulatory References

  1. DailyMed listing for Miconazole Nitrate 2% Cream

Eligibility and Restrictions for Use

Who Can and Cannot Use Micazole 2%?

Eligibility for Micazole (Miconazole) 2% is defined by official regulatory bodies based on documented contraindications and specific population limitations. This information determines who is eligible to use the medicine.

Absolute Contraindications (Must Not Use)

Population/Condition Restriction Basis
Hypersensitivity Known allergy to miconazole, other imidazole antifungals, or any excipients in the product.
Infants (<4 Months) Oral gel formulation is contraindicated due to the risk of choking/pharyngeal obstruction.

Eligibility Constraints

  • Age-Related: Use of most topical formulations is generally not established or not recommended for infants under one month (four weeks) old. Children under two years may require medical consultation for use.
  • Pregnancy and Lactation: Use during pregnancy and breastfeeding is conditional. It should only be used if the healthcare professional deems the potential benefit outweighs the potential risk.
  • Underlying Conditions: Patients with severe hepatic impairment are generally ineligible for systemic forms. Caution is required for use with certain anticoagulants.

What should I know about interactions with other medicines?

Micazole 2% can interact with other medicinal products, with the most clinically significant concerns involving drugs that affect blood clotting. The potential for these interactions exists even with topical, intravaginal, and oral gel formulations, due to the drug's systemic absorption.

Interacting Medicines and Mechanisms

The key mechanism of interaction is Micazole's ability to inhibit certain Cytochrome P450 (CYP) enzymes in the liver, primarily CYP2C9 and CYP3A4. These enzymes are responsible for metabolizing (breaking down) many other medications. Inhibition can lead to increased concentrations and enhanced effects of these co-administered drugs.

1. Oral Anticoagulants (Blood Thinners):

  • Interacting Medicine: Warfarin (and related Coumarin derivatives) is the most critical interaction.
  • Result: Concomitant use with Micazole, regardless of the formulation used, can significantly enhance the anticoagulant effect of Warfarin. This interaction is highly clinically significant and can lead to an increased risk of serious bleeding events.
  • Requirement: Individuals taking Warfarin must have their prothrombin time and International Normalized Ratio (INR) closely monitored when initiating or discontinuing Micazole.

2. Other CYP-Metabolized Drugs:

  • Micazole may also affect the metabolism of other medications that are substrates of CYP2C9 and CYP3A4, such as certain oral hypoglycemics (used for diabetes), phenytoin, and some ergot alkaloids.

3. Hormonal Contraceptives:

  • Micazole can interact with components of some hormonal contraceptives, such as Ethinyl Estradiol and Etonogestrel, leading to an increased risk of certain side effects. Users of intravaginal products should be aware that the product may affect the reliability of latex or rubber contraceptive devices.

Mechanism of Action

Key Fungal Target: Cell Membrane Integrity

The primary mechanism involves Miconazole Nitrate inhibiting the essential fungal enzyme Lanosterol 14alpha-demethylase (CYP51). This blockage prevents the formation of ergosterol, the primary sterol responsible for the structural integrity and flexibility of the fungal cell membrane. The failure to build a proper membrane causes structural impairment, leading to a loss of barrier function and resulting in the leakage of essential cellular components and a loss of cell viability.


Inducing Pathogen Oxidative Stress

A secondary fungicidal mechanism involves the drug interfering with the fungus’s own detoxification system. Miconazole inhibits fungal enzymes like catalases and peroxidases, which are crucial for neutralizing internally produced reactive oxygen species (ROS), such as hydrogen peroxide. By compromising the fungus's ability to defend itself, the drug causes an overwhelming buildup of these toxic compounds. This results in oxidative damage to vital internal structures and contributes to the loss of pathogen viability.

Dosage and Administration Information

How Micazole 2% is Used: Administration Guidelines

Micazole 2% (Miconazole Nitrate) is strictly administered via the topical (skin) or vaginal route, depending on the specific product form and approved indication. The dosing and application schedule must be followed precisely for the duration outlined for the product.


Administration Details

Area of Use Dose and Frequency Treatment Duration Age Constraint
Topical (Skin) Apply a thin layer over the affected area twice daily (morning and night). 4 weeks (for Athlete's Foot/Ringworm); 2 weeks (for Jock Itch). Do not use on children under 2 years unless directed by a doctor.
Vaginal Insert one full applicatorful of the 2% cream. Typically 7 nights in a row. Ask a doctor for children under 12 years.

Procedural Instructions

Preparatory steps and application techniques include:

  • Preparation: The affected skin area must be cleaned and dried thoroughly before each application.
  • Application: The cream should be rubbed in gently until fully absorbed into the skin.
  • Missed Dose: If an application is missed, it should be applied as soon as remembered. However, do not use a double dose to compensate for the skipped one.
  • Special Considerations: For Athlete's Foot, the cream must be applied to the spaces between the toes, and patients are instructed to use well-ventilated shoes and change socks daily as part of the treatment protocol. Treatment must be completed for the full duration specified, even if the condition appears to have resolved earlier.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Micazole 2%

This section provides an overview of the official research studies and clinical trials that have examined Micazole 2%. This is a summary of the available data structure and patterns observed in research, not a guide to treatment or clinical advice.


Research Evidence for Superficial Skin Infections

Research for conditions such as athlete's foot and ringworm has been structured around short-term Randomized Controlled Trials (RCTs). These studies primarily examined immunocompetent adults and adolescents, monitoring two key endpoints: mycological clearance and clinical status, which tracks the change in observable signs like scaling and redness. Studies report patterns related to the measurements of fungal clearance over defined, short treatment periods. However, long-term effects are not fully established because follow-up durations were limited in the primary research.


Research Evidence for Vaginal Yeast Infections

The evidence structure for vaginal yeast infections is built upon RCTs and regulatory trials that focused on non-pregnant, immunocompetent women. The research examined a comprehensive endpoint called therapeutic cure, tracking both mycological status (the absence of the Candida species) and the change in perceived discomfort. Studies report how symptoms evolved in the observed populations during the treatment and at a required check-up visit. Data for certain groups, such as women with recurring infections, remain insufficient.


Evidence in Different Patient Groups and Scientific Uncertainty

Research has explored the evaluation of the formulation across adults and certain pediatric populations (infants over 4 weeks) for Candida-related skin conditions. For fungal nail infections, the findings apply only to the populations studied—typically adults with milder forms—and certainty remains low due to smaller sample sizes and varying evidence quality. In general, comparative evidence is lacking against the most recent non-azole topical antifungals, and there is limited information regarding the risk of recurrence across all studied indications.

Key Studies & References

  1. Label: MICONAZOLE NITRATE cream (Miconazole Nitrate Cream USP, 2%) - DailyMed

Frequently Asked Questions (FAQ)

Common questions about Micazole 2% (FAQ)


Q: Is Micazole 2% available over the counter or is it prescription only?

A: Topical and vaginal creams containing Miconazole Nitrate 2% are commonly classified for non-prescription (over-the-counter) use in the United States and several other regions. This means they can often be purchased without a doctor’s prescription. However, some other specific Miconazole formulations or higher strengths may be restricted to prescription-only use, according to official regulatory labels.

Q: How quickly does Micazole 2% generally start working?

A: Official research and guidelines focus on ensuring the infection is completely cleared over a specified treatment time, which typically ranges from 2 to 4 weeks for common fungal conditions. Clinical studies track progress toward both the elimination of the fungus and the visible improvement of symptoms during this period. A fixed timeline for the initial onset of symptom relief is generally not included in the primary regulatory summaries.

Q: What happens if a dose of Micazole 2% is missed?

A: According to official administration guidance, if an application is missed, the product is intended to be applied as soon as it is remembered. The guidance also clearly states that a double dose should not be used to compensate for the skipped application.

Q: Is it normal to feel a slight tingling sensation after applying Micazole 2%?

A: Official documentation lists several common skin reactions at the application site. These adverse events include a burning sensation, local irritation, redness, and itching. Official documentation lists application-site reactions such as local irritation, burning sensation, redness, and itching.

Q: What is the difference between Micazole 2% and other similar creams?

A: Micazole 2% is a member of a specific drug class called azole antifungals, derived from imidazole. It works by targeting a fungal cell component called ergosterol. Official research overviews commonly indicate that comprehensive comparative evidence against the newest types of non-azole topical antifungals is limited.

Q: Does Micazole 2% interact with common pain relievers?

A: Because topical application results in minimal systemic absorption, the risk for drug interactions is generally low. However, official product information indicates that the drug has the potential to affect the metabolism of certain other medicines that rely on specific CYP450 enzymes, even when used topically.

Q: Can Micazole 2% be used while taking oral medications?

A: Due to the minimal amount of the drug absorbed through the skin, the likelihood of systemic interactions with most oral medications is limited. Nevertheless, the official product information requires consideration for potential interactions with certain specific oral medications, such as oral anticoagulants (blood thinners), because Miconazole may affect their metabolism.

Q: Can Micazole 2% be applied to broken skin?

A: The product is designed for localized action, and official guidance for some formulations advises against application on broken skin or large areas of damaged skin.

Q: Is Micazole 2% suitable for people with sensitive skin?

A: Official safety data lists application site reactions such as local irritation, redness, and contact dermatitis (a skin rash). Furthermore, some products contain inactive ingredients, such as preservatives or antioxidants, which regulatory documents note may cause local skin reactions.

Q: Are there any warnings about using Micazole 2% with certain medical conditions?

A: Official documents list hypersensitivity (known allergy to the drug or its components) as a primary reason not to use the product. Additionally, warnings advise caution or monitoring for individuals with specific underlying conditions, such as diabetes (due to potential drug interactions), or for those with severe hepatic impairment (for systemic forms).

Q: Does Micazole 2% contain any common allergens like lanolin or parabens?

A: The formulation base of the product contains various inactive ingredients, which can differ depending on the manufacturer and specific product form (cream, powder, etc.). The official Drug Facts labels list these excipients, which may include substances like benzoic acid or butylated hydroxyanisole.

Q: Does Micazole 2% have a strong smell or stain clothing?

A: Safety documents typically describe the product as having no available odor. Official warnings advise certain users, such as those using the vaginal product, to wear cotton underwear, as certain constituents in the cream or ovule formulation may potentially damage synthetic materials.

Q: Is there a generic version of Micazole 2%?

A: Yes, Miconazole Nitrate 2% is the generic name of the active drug ingredient. Micazole 2% is a brand name in this context, and there are many generic products containing the same active ingredient at the same concentration available from various packagers.

Q: Can Micazole 2% be used long-term?

A: Official guidance specifies short treatment durations, typically ranging from 2 to 4 weeks, depending on the infection type. Research evidence that supports the use of the product is based on these short-term trials, and the long-term effects of chronic use are not fully established in the primary regulatory research.

Q: Can Micazole 2% be used for acne or bacterial infections?

A: No. The official uses (indications) for Micazole 2% are restricted to the treatment of fungal infections, such as athlete's foot, jock itch, and ringworm. The product is not indicated by regulatory bodies for use against bacterial infections or conditions like acne.

Q: How does the cream get absorbed by the body?

A: The cream is designed for localized action. Official pharmacokinetic data indicate that following topical application to the skin or vagina, only small amounts of the Miconazole Nitrate are absorbed into the systemic circulation (the bloodstream).

Q: Is Micazole 2% safe for use on the face?

A: Official caution is advised regarding application to sensitive areas, including the eyes, mouth, mucous membranes, and face.

Q: Can you apply makeup or lotion after using Micazole 2%?

A: Official guidance includes the need to avoid the use of other topical products, including makeup or lotions, on the affected area unless recommended by a healthcare professional. For the product to work correctly, instructions typically require that the cream be rubbed in gently until fully absorbed.

Q: Can Micazole 2% be used by people with diabetes?

A: Individuals with diabetes are listed in official documents as a population that may be more susceptible to recurring fungal infections and who should seek medical consultation before using the product. A specific interaction warning also exists regarding the potential effect on certain oral hypoglycemic (diabetes) medications.

Q: Is there any research on Micazole 2% effectiveness for unusual fungal strains?

A: Official indications and research summaries focus on common fungal pathogens, including various Candida species and dermatophytes (ringworm fungi). Studies confirm the product's broad-spectrum efficacy against a range of these typical fungal pathogens that cause superficial infections.

Q: What does official guidance say about accidentally swallowing a small amount of Micazole 2%?

A: The official Drug Facts label contains a standard warning that if the product is accidentally swallowed, the warning indicates that medical help is necessary. This includes contacting a Poison Control Center for guidance.

Q: Is there a concern about using Micazole 2% in hot or humid environments?

A: Official directions for use often include practices intended to reduce moisture and warmth. For example, for conditions like athlete's foot, these practices include changing socks daily and using well-ventilated shoes, as fungal infections thrive in moist conditions.

Q: What is the official classification of Micazole 2% (e.g., Schedule 1, 2, 3)?

A: The legal classification of Miconazole 2% varies by country and region. For instance, in some countries like the US, it is widely classified as a non-prescription (OTC) drug. In other jurisdictions, it may be classified as a Pharmacy Medicine or similar scheduled product, depending on the formulation and approved use.

Q: Have there been any recent changes to the official labeling of Micazole 2%?

A: Official drug applications and supplement letters document that regulatory bodies continuously monitor and periodically approve changes to the product labeling and formulations. This process ensures the information stays up-to-date with the latest safety and efficacy data.

Q: How is Micazole 2% different from a generic antifungal named Miconazole?

A: Miconazole is the name of the active drug ingredient. Micazole 2% is the brand name used in this context, which contains the same active ingredient, Miconazole Nitrate, at the 2% concentration, as its generic counterparts. Both are essentially the same medicine.

Q: Can Micazole 2% be used for non-fungal conditions?

A: No. Official indications clearly restrict the use of the product to treating fungal infections caused by susceptible fungi, such as ringworm, jock itch, and athlete’s foot. The product is not indicated for treating non-fungal conditions.

Q: How long after the use of Micazole 2% should symptoms be reassessed?

A: Official guidance for some non-prescription uses describes when a clinician should be consulted, such as if symptoms do not improve within 3 days, persist for more than 7 days, or recur quickly. In clinical trials, the 'test-of-cure' visit is typically scheduled between days 21 and 30 after starting treatment.

Q: Are there different strengths of Micazole available besides 2%?

A: Yes. While the topical cream is commonly available at the 2% strength, the active ingredient Miconazole is available in various other concentrations and forms for different indications. These include 4% vaginal cream, 100 mg or 200 mg vaginal suppositories, and 50 mg buccal tablets, depending on the product’s approval.

How should Micazole 2% be stored and disposed of?

How to Store and Dispose of Micazole 2%?

The storage and disposal of Micazole 2% (Miconazole Nitrate) must strictly follow the requirements documented in official regulatory labeling.


Storage and Handling Requirements

Classification Requirement
Temperature Store at Controlled Room Temperature, typically 15 C to 30 C (59 F to 86 F), or below 30 C.
Environment The product must be protected from light, stored in a dry place, and must not freeze.
Child Safety Keep out of the sight and reach of children.

Disposal Instructions

Expired or unused medicine must be disposed of in accordance with local requirements. Certain components, such as applicators, must not be flushed in the toilet to prevent environmental contamination.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Micazole 2% found in:

A-Z Index: